Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer (ANITA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03598270 |
Recruitment Status :
Active, not recruiting
First Posted : July 26, 2018
Last Update Posted : February 8, 2022
|
Sponsor:
Grupo Español de Investigación en Cáncer de Ovario
Collaborators:
Hoffmann-La Roche
GlaxoSmithKline
AGO Study Group
Belgian Gynaecological Oncology Group
ARCAGY/ GINECO GROUP
Israeli Society of Gynecologic Oncology
MaNGO
Information provided by (Responsible Party):
Grupo Español de Investigación en Cáncer de Ovario
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | August 2024 |
Estimated Study Completion Date : | January 2025 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):